APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 75 filers reported holding APYX MEDICAL CORPORATION in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,030 | +74.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,880 | +23.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $2,340 | -96.2% | 1,000 | -89.4% | 0.00% | -100.0% |
| Q1 2022 | $62,000 | -50.4% | 9,424 | -3.1% | 0.01% | -52.6% |
| Q4 2021 | $125,000 | -22.4% | 9,724 | -16.2% | 0.02% | -29.6% |
| Q3 2021 | $161,000 | -10.6% | 11,599 | -33.5% | 0.03% | -12.9% |
| Q2 2021 | $180,000 | -1.1% | 17,439 | -7.4% | 0.03% | -13.9% |
| Q1 2021 | $182,000 | -3.7% | 18,839 | -28.2% | 0.04% | -10.0% |
| Q4 2020 | $189,000 | +52.4% | 26,230 | -0.1% | 0.04% | +29.0% |
| Q3 2020 | $124,000 | -22.5% | 26,266 | -8.7% | 0.03% | -35.4% |
| Q2 2020 | $160,000 | -3.0% | 28,776 | -37.4% | 0.05% | -43.5% |
| Q1 2020 | $165,000 | -57.5% | 45,950 | +0.9% | 0.08% | -50.9% |
| Q4 2019 | $388,000 | +26.4% | 45,550 | -6.6% | 0.17% | +4.8% |
| Q3 2019 | $307,000 | -21.5% | 48,750 | -11.0% | 0.16% | -22.2% |
| Q2 2019 | $391,000 | +2.9% | 54,800 | -8.9% | 0.21% | -7.0% |
| Q1 2019 | $380,000 | – | 60,150 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 2,238,515 | $31,003,000 | 4.38% |
| Taylor Frigon Capital Management LLC | 574,199 | $7,953,000 | 2.56% |
| Millrace Asset Group, Inc. | 210,869 | $2,921,000 | 1.82% |
| Cowen Prime Advisors LLC | 251,759 | $3,487,000 | 1.30% |
| COWEN AND COMPANY, LLC | 1,879,003 | $26,024,000 | 1.23% |
| RTW INVESTMENTS, LP | 3,398,279 | $47,066,000 | 0.71% |
| PURA VIDA INVESTMENTS, LLC | 857,018 | $11,870,000 | 0.36% |
| WOLFF WIESE MAGANA LLC | 36,907 | $511,000 | 0.36% |
| EAM Investors, LLC | 128,560 | $1,781,000 | 0.30% |
| WHITE PINE CAPITAL LLC | 57,178 | $792,000 | 0.24% |